2007
DOI: 10.1124/jpet.107.127258
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs

Abstract: Transient receptor potential vanilloid 1 (TRPV1) plays an integral role in modulating the cough reflex, and it is an attractive antitussive drug target. The purpose of this study was to characterize a TRPV1 antagonist, 4-(3-trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic acid (5-trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), against the guinea pig TRPV1 receptor in vitro followed by a proof-of-principle study in an acid-induced model of cough. The affinity of JNJ17203212 for the recombinant guinea pi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(40 citation statements)
references
References 40 publications
0
40
0
Order By: Relevance
“…Sensory nerves expressing TRPV1 innervate the airways, and inhalation of capsaicin elicits cough (Laude et al 1993). TRPV1 antagonists have shown efficacy in suppressing cough and airways hyper-responsiveness in guinea pigs induced by capsaicin and citric acid (Bhattacharya et al 2007;Lalloo et al 1995) and, more relevantly, by ovalbumin (Delescluse et al 2012). Cough suppression has been an end point in at least one clinical trial for a TRPV1 antagonist (Eid 2011).…”
Section: Trpv1 Antagonists and Agonists In Vivomentioning
confidence: 98%
“…Sensory nerves expressing TRPV1 innervate the airways, and inhalation of capsaicin elicits cough (Laude et al 1993). TRPV1 antagonists have shown efficacy in suppressing cough and airways hyper-responsiveness in guinea pigs induced by capsaicin and citric acid (Bhattacharya et al 2007;Lalloo et al 1995) and, more relevantly, by ovalbumin (Delescluse et al 2012). Cough suppression has been an end point in at least one clinical trial for a TRPV1 antagonist (Eid 2011).…”
Section: Trpv1 Antagonists and Agonists In Vivomentioning
confidence: 98%
“…While TRPV1 is activated at relatively low pH, inflammatory mediators and injury signals can augment the sensitivity of TRPV1 to acidity, and acidity can in turn hypersensitize TRPV1 (73). While it is unlikely that the pH in the lung would drop low enough to activate TRPV1 during inhalation of a TIH, repeated inhalation or underlying inflammation may facilitate TRPV1 to become hypersensitive and therefore triggered by an exposure to a gaseous acid (73)(74)(75)(76)(77)(78)(79)(80). For instance, TRPV1 is sensitized by the potent proinflammatory signal, bradykinin (81).…”
Section: Acid-sensing Ion Channels: Trpv1mentioning
confidence: 99%
“…A recent paper has shown that citric acid evoked coughing in anesthetized guinea pigs is mediated by direct activation of capsaicin-insensitive vagal afferent nerves most likely through sequential activation of acid-sensing ion channels and chloride channels without the contribution of TRPV1 (Canning et al 2006). However, previous studies using first-generation antagonists (Lalloo et al 1995;Trevisani et al 2004) and more recent evidence with second-generation and chemically unrelated TRPV1 antagonists (Bhattacharya et al 2007;Leung et al 2007) showed that all these drugs selectively inhibited citric acid induced cough in guinea pigs, thus providing robust circumstantial evidence that TRPV1 contributes to acidic-media-induced cough.…”
Section: Cough and Trpv1mentioning
confidence: 92%